Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

DDefinium Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
D

Definium Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder
    Sep 14, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics Announces New Employee Inducement Grants
    Sep 14, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026
    Sep 13, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
    Sep 10, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics Receives Breakthrough Therapy Designation for DT120 (lysergide) Orally Disintegrating Tablet (ODT) in Major Depressive Disorder (MDD) Following Positive Phase 3 Results
    Sep 8, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics Announces New Employee Inducement Grants
    Aug 31, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
    Aug 26, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics Announces New Employee Inducement Grants
    Aug 17, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
    Aug 12, 2026Definium Therapeutics (DFTX) Press Releases
  • Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
    Aug 6, 2026Definium Therapeutics (DFTX) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions